Report
BioNTech SE : Booster shots are needed…and are effective against Omicron
>Low level neutralising antibodies against Omicron after 2-dose schedule - BioNTech together with Pfizer announced preliminary data from laboratory tests, investigating sera from people having received two or three doses of Comirnaty. So far data indicate that sera from people having received two doses of Comirnaty have a 25x times lower level of neutralising antibodies against Omcron vs the wild-type strain. Hence, BioNTech and Pfizer conclude that the two-dose regim...
Underlying
BioNTech SE
Provider
Oddo BHF
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Martial Descoutures
Other Reports on these Companies
Other Reports from Oddo BHF
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.